Manish A. Parikh1, MD; Jonathan Soverow1, MD, MPH; Martin B. Leon1, MD; Patrick Serruys2, MD, PhD; Bo Xu3, MBBS; Zuyi Yuan4, MD; Robayaah Zambahari5, MD; Ajay Kirtane1*, MD, SM
1. Department of Medicine, Division of Cardiology, Columbia University Medical Center/New York Presbyterian Hospital, New York, NY, USA; 2. Department of Interventional Cardiology, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands; 3. Cardiovas
Aims: We assessed long-term outcomes in patients with extra-small (XS) (≤2.25 mm) and small vessels (SV) (>2.25-2.75 mm) treated with the Resolute zotarolimus-eluting stent (R-ZES).